Diagnostic Cardiology at Baxter - U.S.
Corey McClain has a diverse work experience, starting with their current role as the Regionals Sales Director at Bardy Diagnostics, Inc. that began in 2022. Prior to that, they worked at Baxter International Inc. as the Senior Manager, Strategic Solutions from 2021 to 2022, where they collaborated with major IDN customers to enhance connected care and improve clinical outcomes. Before that, Corey held multiple roles at Hillrom, including Senior Manager, Strategic Solutions from 2018 to 2021 and Strategic Sales Executive from 2018 to 2021. In these positions, they provided consultative solutions to executive-level clients in IDNs and ACOs and partnered with healthcare providers to improve performance metrics. Corey's earlier experience includes working at Ecolab, where they served as a Regional Sales Manager from 2015 to 2018 and as a Senior Account Executive from 2011 to 2015.
Corey McClain earned a Bachelor's degree in Business/Corporate Communications from West Virginia University, which was completed between the years 2000 and 2005.
This person is not in any teams
This person is not in any offices
Diagnostic Cardiology at Baxter - U.S.
1 followers
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.